tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Biodexa Pharmaceuticals PLC

BDRX
Add to Watchlist
1.310USD
-0.170-11.49%
Close 07-31 16:00（ET）Quotes delayed by 15 min
591.64KMarket Cap
7.51P/E TTM

Biodexa Pharmaceuticals PLC

1.310
-0.170-11.49%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BDRX Financials

See Biodexa Pharmaceuticals PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Biodexa Pharmaceuticals PLC Earnings Date

Latest Release
Mar 27, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-80.84
98.89%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
FY2018H2
FY2018H1
FY2017H2
FY2017H1
FY2016H2
FY2016H1
FY2015H2
FY2015H1
Financial Indicators
EPS
---109.23
---29.57
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
-100.00%0.00
-100.00%0.00
-63.11%67.09K
-41.49%237.39K
29.19%181.89K
39.04%405.72K
11.13%140.79K
122.38%291.81K
-30.44%126.68K
-64.33%131.22K
-83.08%182.13K
-12.35%367.87K
190.87%1.08M
19.26%419.72K
-85.24%370.18K
-87.70%351.93K
240.63%2.51M
1262.44%2.86M
810.34%736.36K
813.19%210.06K
Net Profit
----
34.78%-1.85M
13.24%-2.47M
21.56%-2.84M
-7.11%-2.84M
-97.25%-3.62M
-15.62%-2.65M
46.87%-1.83M
83.13%-2.30M
25.73%-3.45M
-278.32%-13.61M
-65.79%-4.65M
58.78%-3.60M
44.41%-2.80M
-29.81%-8.73M
47.53%-5.04M
-8.86%-6.72M
-163.59%-9.61M
-94.60%-6.17M
9.44%-3.65M
-77.47%-3.17M
Debt to assets ratio
--3.38%
--4.92%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
----
-100.00%0.00
-100.00%0.00
-63.11%67.09K
-41.49%237.39K
29.19%181.89K
39.04%405.72K
11.13%140.79K
122.38%291.81K
-30.44%126.68K
-64.33%131.22K
-83.08%182.13K
-12.35%367.87K
190.87%1.08M
19.26%419.72K
-85.24%370.18K
-87.70%351.93K
240.63%2.51M
1262.44%2.86M
810.34%736.36K
813.19%210.06K
Operating profit
----
-24.83%-3.80M
6.89%-3.15M
24.91%-3.05M
-3.22%-3.38M
-35.55%-4.06M
-39.17%-3.28M
-5.59%-2.99M
55.39%-2.35M
43.10%-2.84M
-23.60%-5.28M
-15.93%-4.98M
10.97%-4.27M
-16.50%-4.30M
2.87%-4.79M
48.07%-3.69M
36.55%-4.94M
-32.53%-7.11M
-127.81%-7.78M
-21.49%-5.36M
-73.14%-3.41M
Net Profit
----
34.78%-1.85M
13.24%-2.47M
21.56%-2.84M
-7.11%-2.84M
-97.25%-3.62M
-15.62%-2.65M
46.87%-1.83M
83.13%-2.30M
25.73%-3.45M
-278.32%-13.61M
-65.79%-4.65M
58.78%-3.60M
44.41%-2.80M
-29.81%-8.73M
47.53%-5.04M
-8.86%-6.72M
-163.59%-9.61M
-94.60%-6.17M
9.44%-3.65M
-77.47%-3.17M
Balance Sheet
Current assets
16.74%6.55M
18.53%6.74M
-3.08%5.61M
53.95%5.68M
-23.18%5.79M
-60.54%3.69M
47.31%7.53M
39.33%9.35M
-36.22%5.11M
-40.42%6.71M
-31.24%8.02M
158.78%11.27M
-25.55%11.66M
-67.33%4.36M
79.85%15.66M
-25.65%13.33M
2.96%8.71M
25.87%17.93M
-51.38%8.46M
-32.63%14.24M
----
Total current liabilities
-30.43%1.81M
-14.51%3.85M
42.68%2.59M
200.90%4.50M
27.53%1.82M
2.16%1.50M
-48.98%1.43M
-32.32%1.46M
-51.27%2.80M
-53.46%2.16M
107.27%5.74M
142.72%4.65M
-42.74%2.77M
-68.07%1.92M
-10.39%4.83M
-20.14%6.00M
-9.45%5.39M
17.85%7.51M
172.10%5.96M
236.73%6.37M
----
Total assets
3.67%10.79M
32.60%11.30M
64.16%10.41M
95.88%8.52M
-24.43%6.34M
-57.64%4.35M
39.39%8.39M
44.53%10.27M
-35.74%6.02M
-71.96%7.11M
-59.65%9.37M
59.94%25.35M
-15.27%23.22M
-55.12%15.85M
-18.64%27.41M
-22.51%35.31M
-20.91%33.69M
1.57%45.57M
55.45%42.60M
43.84%44.87M
----
Total liabilities
-36.85%2.47M
4.16%4.94M
84.16%3.91M
154.76%4.74M
11.69%2.12M
-4.95%1.86M
-42.29%1.90M
-12.74%1.96M
-43.44%3.29M
-75.88%2.24M
89.00%5.82M
240.86%9.30M
-67.73%3.08M
-73.86%2.73M
51.43%9.54M
18.40%10.44M
-47.26%6.30M
-26.65%8.82M
258.48%11.95M
284.65%12.02M
----
Total equity
28.01%8.33M
68.25%6.36M
54.11%6.51M
51.88%3.78M
-35.00%4.22M
-70.05%2.49M
137.85%6.49M
70.95%8.31M
-23.12%2.73M
-69.69%4.86M
-82.37%3.55M
22.30%16.05M
12.73%20.14M
-47.26%13.12M
-34.76%17.87M
-32.32%24.88M
-10.64%27.39M
11.90%36.76M
27.34%30.65M
17.03%32.85M
----
Cash Flow Statement
Net operating income
----
-140.39%-5.64M
-14.04%-3.51M
14.88%-2.35M
-0.39%-3.08M
-19.31%-2.76M
-35.10%-3.07M
-43.41%-2.31M
59.12%-2.27M
-0.94%-1.61M
-49.42%-5.55M
65.87%-1.60M
39.27%-3.72M
-120.98%-4.68M
18.57%-6.12M
48.49%-2.12M
-26.61%-7.51M
17.04%-4.11M
-72.50%-5.94M
-100.69%-4.95M
-198.32%-3.44M
Net investment
----
122.09%59.63K
-19831.34%-635.11K
-52.39%-269.99K
84.68%-3.19K
-70.02%-177.17K
80.55%-20.81K
-105.41%-104.20K
-53.88%-106.97K
182.71%1.93M
91.24%-69.51K
-132.12%-2.33M
-227.42%-793.52K
3929.79%7.25M
73.32%-242.35K
61.63%-189.40K
-60.53%-908.48K
17.41%-493.61K
-19.08%-565.92K
-32.44%-597.63K
-209.89%-475.23K
Net financing
----
-7.04%2.99M
-30.56%3.46M
2860.76%3.22M
7978.66%4.99M
-98.46%108.66K
-24.24%-63.29K
260.32%7.07M
-116.02%-50.94K
-63.33%1.96M
-96.81%317.89K
218.74%5.35M
18452.07%9.96M
-159.91%-4.51M
25.56%-54.28K
-39.60%7.52M
40.92%-72.92K
6635.76%12.46M
-428.21%-123.42K
-100.87%-190.57K
-96.14%37.60K

FAQs

What are the current assets of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its current assets were 16.49M, with a year-on-year change of 43.14.

What are the total assets of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total assets of Biodexa Pharmaceuticals PLC were 24.10M, with a year-on-year change of 24.65.

What are the total liabilities of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total liabilities of Biodexa Pharmaceuticals PLC were 8.98M, with a year-on-year change of 6.30.

What is the total equity of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total equity of Biodexa Pharmaceuticals PLC was 8.60M, with a year-on-year change of -20.96.

What is the net operating income of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net operating income of Biodexa Pharmaceuticals PLC was -11.46M, with a year-on-year change of 4.76.

What is the net investment of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net investment of Biodexa Pharmaceuticals PLC was -507.69K, with a year-on-year change of 49.85.

What is the net financing of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net financing of Biodexa Pharmaceuticals PLC was 9.85M, with a year-on-year change of -12.02.

What is the Earnings Per Share (EPS) of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -80.84, with a year-on-year change of 98.89.

What is the net income of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net income was -4.82M, with a year-on-year change of 35.73.

What is the Return on Equity (ROE) of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Return on Equity (ROE) was -64.72, with a year-on-year change of 26.57.

What is the Return on Assets (ROA) of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Return on Assets (ROA) was -38.74, with a year-on-year change of 14.39.

What is the operating profit of Biodexa Pharmaceuticals PLC?

According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its operating profit was -11.46M, with a year-on-year change of 4.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy